{"id":"W2313479654","doi":"10.1093/annonc/mdw139","title":"Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor-positive, HER2-negative metastatic breast cancer: patient-reported outcomes from the PALOMA-3 trial","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Pfizer","keywords":"Fulvestrant; Palbociclib; Medicine; Placebo; Internal medicine; Quality of life (healthcare); Breast cancer; Metastatic breast cancer; Oncology; Cancer; Confidence interval; Anastrozole; Gynecology; Estrogen receptor; Tamoxifen","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001935764,0.0006629846,0.0009290233,0.0002555002,0.0002080969,0.00069743,0.0005820367,0.0006583676,0.002326631],"category_scores_gemma":[0.00105185,0.000140155,0.001601401,0.0004209996,0.0003837309,0.0003938548,0.0003889418,0.001537557,0.000237469],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005753263,"about_ca_system_score_gemma":0.000601354,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007562829,"about_ca_topic_score_gemma":0.001502122,"domain_scores_codex":[0.999493,0.0003074682,0.00003043784,0.00005094512,0.00006160063,0.00005658655],"domain_scores_gemma":[0.9994591,0.0001287997,0.000203505,0.00002978938,0.00003168188,0.0001471959],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8936217,0.00565875,0.02368636,0.001882797,0.005469728,0.0001300073,0.00009853752,0.002568103,0.00369097,0.0001481711,0.003932198,0.05911267],"study_design_scores_gemma":[0.7010803,0.1378274,0.1457133,0.0003844427,0.005096798,0.0003965476,0.0001199509,0.002798019,0.001513022,0.0004572686,0.004560463,0.00005255567],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9856201,0.01014912,0.0002112472,0.0004503669,0.0001004889,0.0005663537,0.001541369,0.00002977321,0.001331145],"genre_scores_gemma":[0.9926126,0.00262368,0.0002582697,0.0004652744,0.000143364,0.001123745,0.002215048,0.000007179196,0.0005508692],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002326631,"threshold_uncertainty_score":0.01023746,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08696416881545778,"score_gpt":0.3862310724140349,"score_spread":0.2992669035985772,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}